Learn More
A mong the many sources of effort and expense associated with conducting clinical trials in patients with acute stroke, the reporting and interpretation of adverse events (AE) may be amenable to limitation. More than half of patients experience poststroke AE, and a substantial proportion of the events that are reported are probably incidental rather than(More)
  • 1